HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bjarke M Klein Selected Research

follitropin alfa (Gonal F)

12/2021Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.
1/2017Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bjarke M Klein Research Topics

Disease

3Ovarian Hyperstimulation Syndrome
12/2021 - 01/2017
3Nocturia
04/2013 - 10/2011
2Body Weight (Weight, Body)
12/2021 - 01/2017
1Overactive Urinary Bladder (Overactive Bladder)
10/2011
1Polyuria
10/2011
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2011
1Gastroenteritis
09/2011
1Ulcer
09/2006

Drug/Important Bio-Agent (IBA)

3follitropin deltaIBA
12/2021 - 01/2017
2Hormones (Hormone)IBA
12/2021 - 01/2017
2follitropin alfa (Gonal F)FDA Link
12/2021 - 01/2017
2Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
04/2013 - 04/2012
2TabletsIBA
04/2013 - 04/2012
1GonadotropinsIBA
01/2017
1cytolethal distending toxinIBA
09/2011
1CoagulaseIBA
09/2006

Therapy/Procedure

1Therapeutics
10/2011